Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 9.


Stainthorpe, Angela, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty, Boland, Angela, Beale, Sophie, Dundar, Yenal ORCID: 0000-0002-9847-1622, McEntee, Joanne and Syndikus, Isabel
(2020) Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela, Houten, Rachel, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela, Beale, Sophie, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne and Isabel, Syndikus
(2018) Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12). [Report]


Eldabe, Sam, Duarte, Rui V, Gulve, Ashish, Thomson, Simon, Baranidharan, Ganesan, Houten, Rachel ORCID: 0000-0002-4315-7732, Jowett, Susan, Sandhu, Harbinder, Chadwick, Raymond, Brookes, Morag
et al (show 7 more authors) (2020) Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? a randomised controlled trial. Pain.


Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Beale, Sophie, Boland, Angela, Lambe, Tosin, Dundar, Yenal ORCID: 0000-0002-9847-1622, Kotas, Eleanor and McEntee, Joanne
(2020) Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open.


Martin, Antony P ORCID: 0000-0003-4383-6038, Richards, Sarah, Haycox, Alan ORCID: 0000-0001-6659-4866, Houten, Rachel ORCID: 0000-0002-4315-7732, McLeod, Claire, Braithwaite, Barbara, Clark, Jack O, Bell, Joanne and Clark, Richard E ORCID: 0000-0002-1261-3299
(2016) Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial. JOURNAL OF CLINICAL APHERESIS, 31 (5). 434 - 442.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui
et al (show 1 more authors) (2020) Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24 (2). 1 - +.


Haycox, Alan ORCID: 0000-0001-6659-4866, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, McLeod, Claire, Houten, Rachel ORCID: 0000-0002-4315-7732 and Richards, Sarah
(2014) Through a Glass Darkly: Economics and Personalised Medicine. PharmacoEconomics, 32 (11). 1055 - 1061.


Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Kotas, Eleanor, Boland, Angela, Lambe, Tosin ORCID: 0000-0002-6229-2454 and Duarte, Rui
(2020) A systematic review of health state utility values for thyroid cancer. QUALITY OF LIFE RESEARCH.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Duarte, Rui and Shenoy, Aditya
(2019) A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC CANCER, 19 (1).

This list was generated on Mon Nov 30 02:00:42 2020 GMT.